Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy
Yang, Yun, Guo, Qingcheng, Chen, Xi, Zhang, Junjie, Guo, Huaizu, Qian, Weizhu, Hou, Sheng, Dai, Jianxin, Li, Bohua, Guo, Yajun, Wang, HaoLanguage:
english
Journal:
mAbs
DOI:
10.1080/19420862.2015.1127491
Date:
January, 2016
File:
PDF, 1.88 MB
english, 2016